Advanced search
Publication Cover
Experimental Lung Research Volume 42, 2016 - Issue 7
Submit an article Journal homepage
255
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion

Lin WangDepartment of Oncology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, ChinaCorrespondence[email protected] mailto:[email protected]
,
Yan SunDepartment of Gastroenterology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
,
Jiqun YiDepartment of Oncology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
,
Xiuwen WangDepartment of Oncology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
,
Jizhen LiangDepartment of Oncology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
,
Zhaojun PanDepartment of Oncology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
,
Li LiDepartment of Oncology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China
&
Gaofeng JiangCentral Laboratory, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, China
 show all
Pages 346-353 | Received 15 Mar 2016, Accepted 08 Aug 2016, Published online: 08 Sep 2016

References

  • Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC lung cancer staging project: validation of the proposals for revision. J Thorac Oncol. 2007;2(8):694–705.
  • Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial. CA Cancer J Clin. 2011;61(4):212–236.
  • Costa FF. Non-coding RNAs: meet thy masters. Bioessays. 2010;32(7):599–608.
  • Stein LD. Human genome: end of the beginning. Nature. 2004;431(7011):915–916.
  • Nie L, Wu HJ, Hsu JM, Chang SS, Labaff AM, Li CW, et al. Long non-coding RNAs: versatile master regulators of gene expression and crucial. Am J Transl Res. 2012;4(2):127–150.
  • Wang J, Song YX, Wang ZN. Non-coding RNAs in gastric cancer. Gene. 2015;560(1):1–8.
  • Hauptman N, Glavac D. Long non-coding RNA in cancer. Int J Mol Sci. 2013;14(3):4655–4669.
  • Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719.
  • Zhang EB, Han L, Yin DD, Kong R, De W, Chen J. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol. 2014;31(5):014–0914.
  • Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IFG2. Cancer Res. 2002;62(22):6442–6446.
  • Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res. 2007;67(22):10753–10758.
  • Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, et al. Loss of H19 imprinting in esophageal cancer. Cancer Res. 1996;56(3):480–482.
  • Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, et al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2005;280(33):29625–29636.
  • Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA. 2008;105(34):12417–12422.
  • Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis. 2010;31(3):350–358.
  • Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15(1):59–67.
  • Chundong G, Uramoto H, Onitsuka T, Shimokawa H, Iwanami T, Nakagawa M, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res. 2011;31(4):1141–1145.
  • Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C, et al. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med. 2011;9(166):1479–5876.
  • Stein U, Smith J, Walther W, Arlt F. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle. 2009;8(15):2467–2469.
  • Boccaccio C, Comoglio PM. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer. 2006;6(8):637–645.
  • Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003;4(12):915–925.
  • Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol. 2009;41(12):2356–2359.
  • Guo A, Villen J, Kornhauser J, Lee KA, Stokes MP, Rikova K, et al. Signaling networks assembled by oncogenic EGFR and c-Met. Proc Natl Acad Sci USA. 2008;105(2):692–697.
  • Eder JP, Vande Woude GF, Boerner SA, LoRusso PM. Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res. 2009;15(7):2207–2214.
  • Yarden Y, Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry. 1987;26(5):1443–1451.
  • MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26.
  • Morin PJ. beta-catenin signaling and cancer. Bioessays. 1999;21(12):1021–1030.
  • Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153–183.
  • Kim DH, Sim T. Novel small molecule Raf kinase inhibitors for targeted cancer therapeutics. Arch Pharm Res. 2012;35(4):605–615.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.